• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科癌症研究的最新进展。

Recent Advances in Pediatric Cancer Research.

机构信息

Pediatric Oncology Branch, NCI, Bethesda, Maryland.

Osteosarcoma Institute, Dallas, Texas.

出版信息

Cancer Res. 2021 Dec 1;81(23):5783-5799. doi: 10.1158/0008-5472.CAN-21-1191. Epub 2021 Sep 24.

DOI:10.1158/0008-5472.CAN-21-1191
PMID:34561271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9725930/
Abstract

Over the past few years, the field of pediatric cancer has experienced a shift in momentum, and this has led to new and exciting findings that have relevance beyond pediatric malignancies. Here we present the current status of key aspects of pediatric cancer research. We have focused on genetic and epigenetic drivers of disease, cellular origins of different pediatric cancers, disease models, the tumor microenvironment, and cellular immunotherapies.

摘要

在过去的几年中,儿科癌症领域的发展势头发生了转变,这带来了新的令人兴奋的发现,这些发现与儿科恶性肿瘤以外的领域相关。在这里,我们介绍儿科癌症研究的当前状况。我们重点介绍了疾病的遗传和表观遗传驱动因素、不同儿科癌症的细胞起源、疾病模型、肿瘤微环境和细胞免疫疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/798c/9725930/1fd3e600f947/nihms-1745031-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/798c/9725930/2f0f4165516e/nihms-1745031-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/798c/9725930/1fd3e600f947/nihms-1745031-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/798c/9725930/2f0f4165516e/nihms-1745031-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/798c/9725930/1fd3e600f947/nihms-1745031-f0002.jpg

相似文献

1
Recent Advances in Pediatric Cancer Research.儿科癌症研究的最新进展。
Cancer Res. 2021 Dec 1;81(23):5783-5799. doi: 10.1158/0008-5472.CAN-21-1191. Epub 2021 Sep 24.
2
Advances and Challenges in Pediatric and Childhood Cancers.儿科和儿童癌症的进展与挑战。
Cancer Cell. 2020 Oct 12;38(4):429-432. doi: 10.1016/j.ccell.2020.09.013.
3
Molecular Markers of Pediatric Solid Tumors-Diagnosis, Optimizing Treatments, and Determining Susceptibility: Current State and Future Directions.儿科实体瘤的分子标志物——诊断、优化治疗和易感性评估:现状与未来方向。
Cells. 2022 Apr 6;11(7):1238. doi: 10.3390/cells11071238.
4
Genomics and epigenomics in novel schizophrenia drug discovery: translating animal models to clinical research and back.新型精神分裂症药物研发中的基因组学与表观基因组学:从动物模型到临床研究再回归
Expert Opin Drug Discov. 2015 Feb;10(2):125-39. doi: 10.1517/17460441.2015.976552. Epub 2014 Oct 25.
5
Cancer epigenomics: beyond genomics.癌症表观基因组学:超越基因组学。
Curr Opin Genet Dev. 2012 Feb;22(1):50-5. doi: 10.1016/j.gde.2012.02.008. Epub 2012 Mar 6.
6
The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities.儿童实体瘤网络:发育生物学和肿瘤学研究界的新资源。
Dev Biol. 2016 Mar 15;411(2):287-293. doi: 10.1016/j.ydbio.2015.03.001. Epub 2015 Jun 9.
7
Single-Cell Analyses in the Multi-omics Era.多组学时代的单细胞分析
Cancer Cell. 2020 Jul 13;38(1):9-10. doi: 10.1016/j.ccell.2020.06.015.
8
Advancing Cancer Research and Medicine with Single-Cell Genomics.单细胞基因组学推动癌症研究和医学发展。
Cancer Cell. 2020 Apr 13;37(4):456-470. doi: 10.1016/j.ccell.2020.03.008.
9
Onco-Multi-OMICS Approach: A New Frontier in Cancer Research.肿瘤多组学方法:癌症研究的新前沿。
Biomed Res Int. 2018 Oct 3;2018:9836256. doi: 10.1155/2018/9836256. eCollection 2018.
10
The impact of genomics on pediatric research and medicine.基因组学对儿科研究和医学的影响。
Pediatrics. 2012 Jun;129(6):1150-60. doi: 10.1542/peds.2011-3636. Epub 2012 May 7.

引用本文的文献

1
Epigenetic Inactivation of RIPK3-Dependent Necroptosis Augments Cisplatin Chemoresistance in Human Osteosarcoma.RIPK3 依赖性坏死性凋亡的表观遗传失活增强了人骨肉瘤对顺铂的化疗耐药性。
Int J Mol Sci. 2025 Apr 18;26(8):3863. doi: 10.3390/ijms26083863.
2
SETDB1 amplification in osteosarcomas: Insights from its role in healthy tissues and other cancer types.骨肉瘤中SETDB1基因扩增:基于其在健康组织及其他癌症类型中作用的见解
Oncotarget. 2025 Feb 12;16:51-62. doi: 10.18632/oncotarget.28688.
3
Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks.

本文引用的文献

1
A Population-Based Analysis of 30-Year Mortality among Five-Year Survivors of Adolescent and Young Adult Cancer: The Roles of Primary Cancer, Subsequent Malignancy, and Other Health Conditions.青少年和青年癌症五年幸存者30年死亡率的基于人群分析:原发性癌症、后续恶性肿瘤及其他健康状况的作用
Cancers (Basel). 2021 Aug 5;13(16):3956. doi: 10.3390/cancers13163956.
2
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors.使用MSK-IMPACT进行前瞻性泛癌种胚系检测为751例儿童实体瘤患者的临床转化提供了信息。
Nat Cancer. 2021 Mar;2:357-365. doi: 10.1038/s43018-021-00172-1. Epub 2021 Feb 15.
3
蒽环类药物所致小儿癌症幸存者高血压:揭示长期心血管风险
Egypt Heart J. 2024 Jun 7;76(1):71. doi: 10.1186/s43044-024-00506-1.
4
The Battlefield of Chemotherapy in Pediatric Cancers.小儿癌症化疗的战场
Cancers (Basel). 2023 Mar 24;15(7):1963. doi: 10.3390/cancers15071963.
5
Effect of concurrent training on physical performance and quality of life in children with malignancy: A systematic review and meta-analysis.同步训练对恶性肿瘤患儿身体机能和生活质量的影响:系统评价和荟萃分析。
Front Public Health. 2023 Mar 17;11:1127255. doi: 10.3389/fpubh.2023.1127255. eCollection 2023.
6
Mass Spectrometry Contribution to Pediatric Cancers Research.质谱技术在儿科癌症研究中的应用
Medicina (Kaunas). 2023 Mar 20;59(3):612. doi: 10.3390/medicina59030612.
7
CAR-T Therapies in Solid Tumors: Opportunities and Challenges.嵌合抗原受体 T 细胞疗法在实体瘤中的应用:机遇与挑战。
Curr Oncol Rep. 2023 May;25(5):479-489. doi: 10.1007/s11912-023-01380-x. Epub 2023 Feb 28.
8
Exosomes loaded with miR-665 inhibit the progression of osteosarcoma and .装载有miR-665的外泌体抑制骨肉瘤的进展以及…… (原文此处不完整)
Am J Transl Res. 2022 Oct 15;14(10):7012-7026. eCollection 2022.
9
Zebrafish: A Useful Animal Model for the Characterization of Drug-Loaded Polymeric NPs.斑马鱼:用于表征载药聚合物纳米颗粒的有用动物模型。
Biomedicines. 2022 Sep 11;10(9):2252. doi: 10.3390/biomedicines10092252.
10
Decoding the multidimensional signatures of resident and expanded natural killer cells generated from perinatal blood.解码围产期血液中产生的驻留型和扩增型自然杀伤细胞的多维特征。
Am J Cancer Res. 2022 May 15;12(5):2132-2145. eCollection 2022.
Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma.
肿瘤微环境的免疫基因组决定因素与高危神经母细胞瘤的优越生存相关。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002417.
4
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.横纹肌肉瘤的基因组分类和临床结局:国际联盟的报告
J Clin Oncol. 2021 Sep 10;39(26):2859-2871. doi: 10.1200/JCO.20.03060. Epub 2021 Jun 24.
5
Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma.癌症易感基因中的致病变异体在儿童和青年横纹肌肉瘤患者中的研究
JCO Precis Oncol. 2021 Jan 11;5. doi: 10.1200/PO.20.00218. eCollection 2021.
6
Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.儿童癌症:发病情况、治疗及二次原发性恶性肿瘤风险
Cancers (Basel). 2021 May 26;13(11):2607. doi: 10.3390/cancers13112607.
7
NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical Outcome.在儿科肿瘤中鉴定出的NTRK融合:发生率、融合伴侣及临床结局
JCO Precis Oncol. 2021 Jan 14;1. doi: 10.1200/PO.20.00250. eCollection 2021.
8
Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes.转移性骨肉瘤中免疫排斥的途径与患者预后不良相关。
J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2020-001772.
9
Quality of Life in Adult and Pediatric Patients with Tropomyosin Receptor Kinase Fusion Cancer Receiving Larotrectinib.拉罗替尼治疗原肌球蛋白受体激酶融合癌成人和儿科患者的生活质量。
Curr Probl Cancer. 2021 Dec;45(6):100734. doi: 10.1016/j.currproblcancer.2021.100734. Epub 2021 Apr 2.
10
Comprehensive germline-genomic and clinical profiling in 160 unselected children and adolescents with cancer.在 160 名未经选择的癌症儿童和青少年中进行全面的种系基因组和临床分析。
Eur J Hum Genet. 2021 Aug;29(8):1301-1311. doi: 10.1038/s41431-021-00878-x. Epub 2021 Apr 12.